Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 58,126 shares at $120.19 ($7.0M) on 2025-09-10, disclosed to the SEC on 2025-09-11.
Seasonal sale ($7.0M) by Director — this insider has traded RGEN in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.34 | 96 | $11K | 0.2% |
| 2 | $118.32 | 1,108 | $131K | 1.9% |
| 3 | $118.32 | 1,108 | $131K | 1.9% |
| 4 | $119.64 | 3,262 | $390K | 5.6% |
| 5 | $119.64 | 3,262 | $390K | 5.6% |
| 6 | $120.19 | 14,882 |
| $1.8M |
| 25.5% |
| 7 | $120.19 | 14,882 | $1.8M | 25.5% |
| 8 | $121.42 | 7,584 | $921K | 13.1% |
| 9 | $121.42 | 7,584 | $921K | 13.1% |
| 10 | $122.23 | 2,179 | $266K | 3.8% |
| 11 | $122.23 | 2,179 | $266K | 3.8% |
| Total | $120.52 avg | 58,126 | $7.0M | 100% |
| Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |
| RGEN | SELL | 2024-11-22 | $6.8M | — | Filing → |